VIEWPOINTS PharmaShots Interview: Marc Meachem Shares Insight on the ViiV’s 2021 Commitment to the CommunityBySenior EditorApril 7, 20210Comments
VIEWPOINTS PharmaShots Interview: NeuBase Therapeutics’ Dietrich Stephan Shares Insight on its Approach to Genetic MedicineBySenior EditorApril 6, 20210Comments
VIEWPOINTS PharmaShots Interview: Eli Lilly’s Marie Schiller Shares Insight on the Collaboration with Welldoc on New Version of BlueStar AppBySenior EditorApril 5, 20210Comments
VIEWPOINTS PharmaShots Interview: Cardiff Oncology’s Mark Erlander Shares Insight on the P-I Data of Onvansertib for Metastatic Colorectal CancerBySenior EditorMarch 31, 20210Comments
VIEWPOINTS PharmaShots Interview: Dr. Sezer, Peter C. Adamson and Israel Lowy Share Insight on the US FDA’s Approval of Libtayo (cemiplimab) in Patients with NSCLC with High PD-L1 ExpressionBySenior EditorMarch 30, 20210Comments
VIEWPOINTS PharmaShots Interview: Takeda’s Nirav Desai Shares Insight on Data of TAK-721 Presented at ACG 2020BySenior EditorMarch 29, 20210Comments
VIEWPOINTS PharmaShots Interview: Myriad Genetics’ Dr. Todd D. Cohen Shares Insight on Prolaris Test’s Ability to Guide Prostate Cancer TreatmentBySenior EditorMarch 25, 20210Comments
